Payment overview · 2025
General Payments
$135.83
1 reported records · 1 companies
Healthcare provider profile · identity verified
Thomas L Johnson, MD
Allopathic & Osteopathic Physicians|Family Medicine · NORWAY, ME · NPI 1265693360
Verified facts
What the public records show
CMS Open Payments records show Thomas L Johnson, MD received $135.83 in general payments during 2025 across 1 reported records.
CORDIS US CORP. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $135.83 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $135.83 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SELUTION SLR PTA Normalized: selution slr pta |
Device | CORDIS US CORP. | $135.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 589 | 196 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 456 | 135 |
| Lisinopril | Lisinopril | 413 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 358 | 112 |
| Omeprazole | Omeprazole | 284 | 84 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 256 | 86 |
| Losartan Potassium | Losartan Potassium | 255 | 82 |
| Metoprolol Succinate | Metoprolol Succinate | 248 | 87 |
| Sertraline Hcl | Sertraline Hcl | 230 | 67 |
| Levothyroxine Sodium | Levothyroxine Sodium | 205 | 64 |
| Simvastatin | Simvastatin | 192 | 60 |
| Furosemide | Furosemide | 166 | 56 |
| Metformin Hcl | Metformin Hcl | 160 | 51 |
| Tamsulosin Hcl | Tamsulosin Hcl | 159 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 155 | 51 |
| Gabapentin | Gabapentin | 151 | 54 |
| Metformin Hcl Er | Metformin Hcl | 149 | 53 |
| Trazodone Hcl | Trazodone Hcl | 116 | 39 |
| Allopurinol | Allopurinol | 111 | 34 |
| Eliquis | Apixaban | 105 | 32 |
| Jardiance | Empagliflozin | 102 | 33 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 97 | 21 |
| Famotidine | Famotidine | 91 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 91 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 90 | 29 |
| Montelukast Sodium | Montelukast Sodium | 72 | 22 |
| Prednisone | Prednisone | 70 | 42 |
| Carvedilol | Carvedilol | 68 | 23 |
| Pantoprazole Sodium | Pantoprazole Sodium | 67 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 29 |
| Potassium Chloride | Potassium Chloride | 65 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 18 |
| Alendronate Sodium | Alendronate Sodium | 56 | 21 |
| Finasteride | Finasteride | 52 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 51 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 45 | 19 |
| Tramadol Hcl | Tramadol Hcl | 45 | 20 |
| Pregabalin | Pregabalin | 44 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 41 | 14 |
| Bupropion Xl | Bupropion Hcl | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 27 |
| Trulicity | Dulaglutide | 39 | 11 |
| Farxiga | Dapagliflozin Propanediol | 38 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 38 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 36 | 12 |
| Atenolol | Atenolol | 36 | 12 |
| Baclofen | Baclofen | 36 | suppressed |
| Ibuprofen | Ibuprofen | 35 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 34 | 15 |
| Ozempic | Semaglutide | 34 | suppressed |
| Rybelsus | Semaglutide | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 33 | 13 |
| Bumetanide | Bumetanide | 32 | suppressed |
| Lamotrigine | Lamotrigine | 32 | suppressed |
| Lovastatin | Lovastatin | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | 11 |
| Xarelto | Rivaroxaban | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Alprazolam | Alprazolam | 26 | suppressed |
| Azithromycin | Azithromycin | 26 | 20 |
| Mirtazapine | Mirtazapine | 26 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Olanzapine | Olanzapine | 25 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 23 | 23 |
| Celecoxib | Celecoxib | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 18 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 22 | 16 |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Nitroglycerin | Nitroglycerin | 20 | 14 |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fentanyl | Fentanyl | 16 | suppressed |
| Meloxicam | Meloxicam | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Lamictal Xr | Lamotrigine | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Latuda | Lurasidone Hcl | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $135.83 · 1 records | CORDIS US CORP. | SELUTION SLR PTA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error